It has been a decade since the first issue of Neurology® Neuroimmunology & Neuroinflammation (N2) launched in June 2014. In these 10 years, N2 has evolved to become a leading journal in clinical and translational neuroimmunology. The parallel timings of the rising impact of the journal and the extraordinary advances in the field of neuroimmunology are not due to serendipity. Dr. Richard Ransohoff, the founding editor, together with Dr. Robert Gross, the editor of Neurology in 2014, shared the vision that the rapidly developing field of autoimmune neurology was going to have a home in N2. I became editor of N2 a few months after the journal was introduced, and now, 10 years later, I am glad to transfer the baton to Dr. Scott Zamvil, professor of neurology at University of California, San Francisco. I have been fortunate to work with Dr. Zamvil in his role as deputy editor during the past 10 years; his enthusiasm, work ethic, and encyclopedic knowledge of neuroscience, particularly in regard to multiple sclerosis (MS), myelin oligodendrocyte glycoprotein (MOG) autoimmunity, neuromyelitis optica (NMO), and animal models make him the ideal person to lead the journal forward. This transition coincides with the first decade of N2, and I would like to express my gratitude to all associate editors, editorial board members, and editorial office staff for their dedication to the journal and readiness to help since day one. Importantly, N2 would not be the journal it is without our authors and readers, and we are all grateful for their work and interest shown during these 10 years.